Clinical Trial Update: A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

View source ↗

Summary

A registration study evaluating the CHIRON RIBA HCV 3.0 SIA diagnostic for Hepatitis C antibody detection has been terminated in China. The sponsor listed is Jo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CHIRON RIBA HCV 3.0 SIA

Snippet

Sponsor: Johnson & Johnson Medical, China | Conditions: Hepatitis C | Status: TERMINATED